DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Imatinib
Imatinib
Tyrosine Kinase Inhibitors Ameliorate Autoimmune Encephalomyelitis in a Mouse Model of Multiple Sclerosis
Management of Chronic Myelogenous Leukemia in Pregnancy
Nilotinib (Tasigna®) EOCCO POLICY
Partial Response to Erlotinib in a Patient with Imatinib-Refractory
The Effects of Combination Treatments on Drug Resistance in Chronic Myeloid Leukaemia: an Evaluation of the Tyrosine Kinase Inhibitors Axitinib and Asciminib H
Pulmonary Toxicities of Tyrosine Kinase Inhibitors
Guideline for Preoperative Medication Management
Newer-Generation EGFR Inhibitors in Lung Cancer: How Are They Best Used?
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New- Onset Type 1 Diabetes Mellitus
Sorafenib Inhibits the Imatinib-Resistant KIT Gatekeeper
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK
2021 Formulary List of Covered Prescription Drugs
Drugs Against Cancer: Stories of Discovery and the Quest for a Cure
EML) and Model List of Essential Medicines for Children (Emlc
HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Imatinib Handout
Top View
Tyrosine Kinase Inhibitor (TKI) Flow Chart for the Treatment Of
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce
Kinase Drug Discovery 20 Years After Imatinib: Progress and Future Directions
Clinical Pharmacokinetics of Imatinib Mesylate
Nilotinib Vs Imatinib in Patients with Newly Diagnosed
Comparative Pharmacology of Tyrosine Kinase Inhibitors for The
(Vismodegib) for Gleevec
Axitinib and Sorafenib Are Potent in Tyrosine Kinase Inhibitor Resistant
Appendix B - Product Name Sorted by Applicant
Intolerant Patients with Chronic Myeloid Leukemia in Blastic Phase
Effect of Tyrosine Kinase Inhibitors on Renal Handling of Creatinine By
Histological Changes of the Rat Liver After Administration of Imatinib Mesylate:An Experimental Study
Cumulative Mechanism of Several Major Imatinib-Resistant Mutations in Abl Kinase
Specialty Pharmacy Distribution Network for IBRANCE® (Palbociclib), INLYTA® (Axitinib), XALKORI® (Crizotinib), BOSULIF® (Bosutinib), and SUTENT® (Sunitinib Malate)
1. Composition Amitriptyline Hydrochloride IP 10Mg Propranolol
Effect of Imatinib on the Biochemical Parameters of the Reproductive Function in Male Swiss Albino Mice
Table 1. Summary of Kinase Inhibitors Approved by the FDA for Treatment